From http://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
19,250 Disclosures Found for Payments from GlaxoSmithKline
Jump to: Important notes about this list.
Show only payments over $250
| Name / Payee | City | State | Company | Year | Category | Amount |
|---|---|---|---|---|---|---|
| Abdulsala Al-Kassab (Payee: Abdulsalam Al-Kassab) | ROCHESTER HILLS | Mich. | GlaxoSmithKline | 2011 | Speaking | $4,950 |
| Abdulsalam Al-Kassab | BLOOMFIELD HILLS | Mich. | GlaxoSmithKline | 2012 | Speaking | $1,750 |
| Abdulsalam Al-Kassab | ROCHESTER HILLS | Mich. | GlaxoSmithKline | 2009 | Speaking | $3,000 |
| ABEGBENGA A ADETOLA (Payee: PPD DEVELOPMENT LP) | WHITTIER | Calif. | GlaxoSmithKline | 2011 | Research | $10,095 |
| Abel Gonzalez | BETHLEHEM | Pa. | GlaxoSmithKline | 2010 | Speaking | $1,500 |
| Abel Gonzalez | BETHLEHEM | Pa. | GlaxoSmithKline | 2009 | Speaking | $1,500 |
| ABEL MURILLO (Payee: ELITE RESEARCH INSTITUTE) | MIAMI | Fla. | GlaxoSmithKline | 2011 | Research | $77,677 |
| ABEL MURILLO (Payee: MEDPACE CLINICAL PHARMACOLOGY UNIT LLC) | MIAMI | Fla. | GlaxoSmithKline | 2011 | Research | $60,105 |
| ABEL MURILLO (Payee: MEDPACE INC) | MIAMI | Fla. | GlaxoSmithKline | 2011 | Research | $145,064 |
| ABEL MURILLO (Payee: ELITE RESEARCH INSTITUTE) | MIAMI | Fla. | GlaxoSmithKline | 2011 | Research | $13,250 |
| Abhilash Vaishnav | DE PERE | Wis. | GlaxoSmithKline | 2010 | Speaking | $9,250 |
| Abhilash Vaishnav | DE PERE | Wis. | GlaxoSmithKline | 2011 | Speaking | $3,000 |
| Abhilash Vaishnav | DE PERE | Wis. | GlaxoSmithKline | 2009 | Speaking | $5,500 |
| Abir Kanaan | WORCESTER | Mass. | GlaxoSmithKline | 2010 | Speaking | $6,750 |
| Abir Kanaan | WORCESTER | Mass. | GlaxoSmithKline | 2009 | Speaking | $14,000 |
| Abraham Chamely | TAMARAC | Fla. | GlaxoSmithKline | 2010 | Speaking | $2,000 |
| Abraham Chamely | TAMARAC | Fla. | GlaxoSmithKline | 2009 | Speaking | $2,300 |
| Abraham Cheriyan | LUFKIN | Texas | GlaxoSmithKline | 2012 | Speaking | $1,625 |
| Abraham Cheriyan | LUFKIN | Texas | GlaxoSmithKline | 2010 | Speaking | $2,000 |
| Abraham Cheriyan | LUFKIN | Texas | GlaxoSmithKline | 2011 | Speaking | $3,000 |
| ABRAHAM FENN CHERIYAN (Payee: TAD CLINICAL RESEARCH) | LUFKIN | Texas | GlaxoSmithKline | 2011 | Research | $4,681 |
| Abraham Ishaaya | LOS ANGELES | Calif. | GlaxoSmithKline | 2010 | Speaking | $5,800 |
| Abraham Ishaaya | LOS ANGELES | Calif. | GlaxoSmithKline | 2011 | Speaking | $3,000 |
| Abraham Ishaaya | LOS ANGELES | Calif. | GlaxoSmithKline | 2009 | Speaking | $13,000 |
| ABRAHAM K POULOSE (Payee: SABATES EYE CENTERS PC) | KANSAS CITY | Mo. | GlaxoSmithKline | 2011 | Research | $2,000 |
| Abraham Katz | EL PASO | Texas | GlaxoSmithKline | 2010 | Speaking | $4,500 |
| Abraham Lerner | SACRAMENTO | Calif. | GlaxoSmithKline | 2009 | Speaking | $2,500 |
| Abraham Nagy | LAS VEGAS | Nev. | GlaxoSmithKline | 2009 | Speaking | $300 |
| Acklema Mohammad | PLEASANTVILLE | N.Y. | GlaxoSmithKline | 2012 | Speaking | $1,126 |
| Acklema Mohammad | BRONX | N.Y. | GlaxoSmithKline | 2010 | Consulting | $1,788 |
| Acklema Mohammad | BRONX | N.Y. | GlaxoSmithKline | 2010 | Speaking | $2,000 |
| Acklema Mohammad | BRONX | N.Y. | GlaxoSmithKline | 2011 | Speaking | $3,750 |
| Acklema Mohammad | BRONX | N.Y. | GlaxoSmithKline | 2009 | Speaking | $4,750 |
| Adam Balin | OREGON | Wis. | GlaxoSmithKline | 2012 | Consulting | $3,600 |
| Adam Balin | OREGON | Wis. | GlaxoSmithKline | 2010 | Consulting | $2,750 |
| Adam Balin | OREGON | Wis. | GlaxoSmithKline | 2011 | Consulting | $2,400 |
| Adam Boruchov | HARTFORD | Conn. | GlaxoSmithKline | 2010 | Speaking | $5,500 |
| Adam Boruchov | HARTFORD | Conn. | GlaxoSmithKline | 2011 | Speaking | $9,000 |
| Adam Brufsky | PITTSBURGH | Pa. | GlaxoSmithKline | 2009 | Speaking | $6,000 |
| Adam Feldman | HAMBURG | Pa. | GlaxoSmithKline | 2010 | Speaking | $1,250 |
| Adam Feldman | HAMBURG | Pa. | GlaxoSmithKline | 2009 | Speaking | $750 |
| Adam Holzberg | VOORHEES | N.J. | GlaxoSmithKline | 2011 | Speaking | $1,000 |
| Adam Holzberg | TRENTON | N.J. | GlaxoSmithKline | 2009 | Speaking | $1,000 |
| Adam Maass | ROGERS | Ark. | GlaxoSmithKline | 2009 | Speaking | $3,000 |
| Adam Rosen | CLEARWATER | Fla. | GlaxoSmithKline | 2012 | Speaking | $4,500 |
| Adam Rosen | CLEARWATER | Fla. | GlaxoSmithKline | 2011 | Speaking | $1,500 |
| Adam Williams | BEND | Ore. | GlaxoSmithKline | 2012 | Speaking | $2,375 |
| Adam Williams | BEND | Ore. | GlaxoSmithKline | 2010 | Speaking | $18,300 |
| Adam Williams | BEND | Ore. | GlaxoSmithKline | 2011 | Speaking | $10,775 |
| Adam Williams | BEND | Ore. | GlaxoSmithKline | 2009 | Speaking | $16,100 |
Source
ProPublica research, based on pharmaceutical company disclosures.
Notes
- Some records include both the practitioner listed by the company and the entity receiving payment. If only one name is listed, it represents both the listed practitioner and payee. For instance, some payments made to a university research lab will list the university as the entity receiving payment, and an individual researcher as the practitioner.
- Companies are continually updating their data, so the most recent additions may not be included in our database.
- A physician on the list may be getting money from other companies that have yet to disclose payments.
- Practitioner names and addresses (city/state) are listed as the companies released them and may vary. For instance, some companies include a middle initial, and others do not. Some companies also list different cities for the same individual. This may happen because professionals may have practices in multiple locations or because they provided different addresses for payment.